解郁除烦胶囊 | China Drugs ListJieyu Chufan capsules | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 药品类型
- 中成药Traditional Chinese medicine
- 治疗领域
- 精神健康与睡眠Mental health & sleep
- 公开来源记录的适应症
- 解郁化痰,清热除烦。适用于轻、中度抑郁症中医辨证属气郁痰阻、郁火内扰证,症见情绪低落、心绪不宁、咽中如有异物、胸脘痞闷、食欲不振、易叹气、失眠多梦、头晕耳鸣、口苦咽干、大便秘结,舌红苔腻、脉弦滑等。In TCM, relieves constraint and resolves phlegm, clears heat and eases restlessness. For mild-to-moderate depression with qi stagnation and phlegm obstruction and internal disturbance by constrained fire. Manifestations include low mood, restlessness, a sensation of a foreign body in the throat, chest or epigastric fullness, poor appetite, frequent sighing, insomnia and excessive dreaming, dizziness and tinnitus, a bitter taste and dry throat, constipation, and a red tongue with a greasy coating and a wiry-slippery pulse.
- 适应症来源与口径
- 来源日期： 2024. 适应症转录自国家医保局公开的企业申报资料；不代表已核实完整的现行说明书。 新增适应症可能由较新的公告或申报资料支持，而非旧版完整说明书；请查看适应症来源。Source date(s): 2024. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label. Additional indications may be supported by newer announcements or submissions rather than the older full label; see the indication sources.
- 说明书信息局限
- 适应症已与官方公开申报资料核对。尚未取得完整原始说明书。Indications checked against an official public submission. The full original prescribing information is still unavailable.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 待逐一核查各市场。Market-by-market verification pending.
- 医保分类
- 已纳入国家医保（乙类）Included in national insurance (Category B)
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保限制
- 该目录条目未另列限定；仍须遵守目录凡例及法定适应症No additional restriction is specified for this NRDL entry; the general NRDL rules and legally approved indications still apply.
- 医保期限
- 2025-01-01 至 2026-12-312025-01-01 to 2026-12-31
- 医保核查说明
- 按成分／剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.